Want to keep learning?

This content is taken from the BSAC's online course, Challenges in Antibiotic Resistance: Gram Negative Bacteria. Join the course to learn more.
Hand with pills

Targeted antimicrobial therapy for urinary sepsis: Case #2

Mr Jenkins was administered meropenem 2g TID and amikacin 1g QD.

Forty-eight hours later he still has a high temperature but his overall clinical condition and the analytical data show frank improvement. No alternative source of infection has been found and his urine and blood cultures have come back positive with a phenotypically identical E. coli in both.

Blue table with three columns: Antibiotic/MIC (ug/mL)/Interpretation.  There are 14 antibiotics listed with their MIC and Susceptibility or Resistance noted

The question now is how would you continue antimicrobial therapy?

There are several options but before going into the therapeutic options let’s summarise the case:

  • Mr Jenkins had a (severe) urinary sepsis and we have good evidence of the etiological agent: an ESBL-producing E. coli.

  • Although he is still febrile, the clinical course is favourable.

  • No evidence of abscess or urinary obstruction has been found.

Share this article:

This article is from the free online course:

Challenges in Antibiotic Resistance: Gram Negative Bacteria


Get a taste of this course

Find out what this course is like by previewing some of the course steps before you join: